News - Copaxone, Momenta Pharmaceuticals


Popular Filters

Court ruling favors Mylan in Copaxone patent dispute


A US court has dismissed claims that US generic drugmaker Mylan (Nasdaq: MYL) infringed four patents…

CopaxoneGenericsMomenta PharmaceuticalsMylan LaboratoriesNatco PharmaNeurologicalNorth AmericaPatentsSandozTeva Pharmaceutical Industries

Teva prevails in Copaxone law suit with Mylan/Natco and Sandoz/Momenta


Israel-headquartered Teva Pharmaceutical Industries (Nasdaq: TEVA) says that the US District Court for…

CopaxoneGenericsLegalMomenta PharmaceuticalsMylan LaboratoriesNatco PharmaNeurologicalNorth AmericaPatentsPharmaceuticalSandozTeva Pharmaceutical Industries

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top